Mechanisms responsible for tumor-induced immune suppression in melanoma include PD-L1 overexpression in the tumor, and PDL-L1+ tumor-derived exosomes are reported to interfere with patients’ responses to oncological immunotherapies3,4. The gene discussed is CD274; the disease is melanoma.